Legal & General Group Plc - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$69,115,831
-6.9%
2,546,638
+5.5%
0.02%0.0%
Q2 2023$74,225,590
-8.6%
2,414,630
+7.2%
0.02%
-17.2%
Q1 2023$81,189,931
-8.2%
2,253,400
+0.6%
0.03%
-14.7%
Q4 2022$88,482,698
-3.3%
2,238,936
-1.7%
0.03%
-5.6%
Q3 2022$91,514,000
-2.5%
2,277,597
+2.0%
0.04%
+9.1%
Q2 2022$93,888,000
+13.4%
2,233,295
+5.1%
0.03%
+32.0%
Q1 2022$82,784,000
+12.7%
2,124,840
+15.3%
0.02%
+13.6%
Q4 2021$73,425,000
+35.9%
1,842,516
+23.2%
0.02%
+22.2%
Q3 2021$54,031,000
-10.4%
1,495,030
+1.6%
0.02%
-10.0%
Q2 2021$60,306,000
-1.4%
1,471,237
+4.9%
0.02%
-13.0%
Q1 2021$61,180,000
+158.1%
1,402,572
+196.2%
0.02%
+155.6%
Q4 2020$23,702,000
+2039.2%
473,579
+1698.4%
0.01%
Q3 2020$1,108,000
-65.6%
26,333
-60.3%
0.00%
-100.0%
Q2 2020$3,219,00066,3520.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$244,378,00079.54%
Vantage Consulting Group Inc 7,862,542$284,152,00060.85%
Memorial Sloan Kettering Cancer Center 2,680,644$96,878,00060.36%
Indie Asset Partners, LLC 701,323$25,346,00020.53%
HARVARD MANAGEMENT CO INC 7,142,856$258,143,00015.13%
Bleichroeder LP 1,115,980$40,332,0006.55%
Overbrook Management Corp 785,132$28,375,0006.16%
Geo Capital Gestora de Recursos Ltd 194,305$7,022,0003.21%
Brown University 621,759$22,470,0003.05%
Graypoint LLC 610,584$22,067,0002.71%
View complete list of ROYALTY PHARMA PLC shareholders